Literature DB >> 32184577

Reliability and Validity of the LifeWindows Information-Motivation-Behavioral Skills Antiretroviral Therapy Adherence Questionnaire Among HIV+ Patients in Shanghai.

Zihe Peng1, Yuelin Yu1, Wei Wei2, Yongchun Hou2, Zhenyu Sun3, Ying Wang4, Lin Zhang5, Ying Zhou5, Qian Wang1, Yong Cai1.   

Abstract

OBJECTIVE: The purpose of this article was to examine the validity and reliability of the LifeWindows Information-Motivation-Behavioral Skills Antiretroviral Therapy (ART) Adherence Questionnaire (LW-IMB-AAQ) among HIV+ patients in Shanghai.
METHODS: We surveyed 426 HIV+ patients in Shanghai's Putuo District to examine the validity and reliability of the questionnaire. The questionnaire includes self-reported demographic characteristics, the modified version of the Community Programs for Clinical Research on AIDS Antiretroviral Medication Self-Report (CPCRA) and LW-IMB-AAQ. CPCRA was used to calculate ART adherence. LW-IMB-AAQ, including the information section, the motivation section and the behavioral skills section, was used to analyze patients' ART adherence. We analyzed data by means, standard deviation, critical ratio, and item-total correlation. Reliability was assessed by internal consistency, split-half reliability, and test-retest reliability. Validity was assessed by exploratory factor analysis (EFA), confirmatory factor analysis (CFA), convergent validity and discriminant validity.
RESULTS: Item analysis showed that except for motivation item 1, all items were acceptable. For reliability, Cronbach's alpha coefficients for the three sections and the total scale were all higher than 0.7, with interclass correlation coefficients (ICC) all higher than 0.6 (p<0.001). The Spearman-Brown coefficient for the total scale was 0.825. For validity, results showed that the information section could be divided into two subscales, motivation section and behavioral skills section could be divided into three and two subscales, respectively. The final model demonstrated good validity (p=0.471, χ 2/df=0.960, CFI=1.000, GFI=0.994 and RMSEA<0.001) without motivation item 4.
CONCLUSION: Excluding motivation items 1 and 4, the LifeWindows Information-Motivation-Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ) demonstrated good validity and reliability among HIV+ patients in Shanghai.
© 2020 Peng et al.

Entities:  

Keywords:  China; HIV; IMB model; reliability; validity

Year:  2020        PMID: 32184577      PMCID: PMC7062391          DOI: 10.2147/PPA.S234041

Source DB:  PubMed          Journal:  Patient Prefer Adherence        ISSN: 1177-889X            Impact factor:   2.711


Introduction

HIV (Human Immunodeficiency Virus) has long been a public health problem in the world since the first AIDS cases were reported in 1981. Although the estimated national HIV prevalence rate in China was around 0.06% in 2014, lower than that (0.35%) in the United States, yet, the annual percentage growth of HIV infection in China increased dramatically with a 16.3% increase between 2004 and 2013.1,2 The UN puts forward a 90-90-90 UNAIDS goal, hoping by 2020, 90% of all people living with HIV be aware of their HIV status, 90% HIV+ patients receive sustained ART, and 90% of those already receiving ART manage to gain viral suppression.3 This suggests that optimal adherence to antiretroviral therapy (ART) plays a significant role in helping HIV+ patients achieve effective viral suppression, better immune functions, and lower HIV transmissions.4–8 Although the ART therapy has been widely available to HIV+ patients, especially in developed and fast-developing countries, yet, patient adherence to the treatment differed, which can lead to markedly different outcomes. Studies showed that HIV+ patients could achieve the durable status of having undetected virus load at a 90–95% adherence level.9–13 However, the average proportion of adherence is relatively low. One meta-analysis research found that the overall adherence was 70% (95% CI 63–76; I = 98%) among Latin American and Caribbean population. Another meta-analytic review of 84 studies across 20 countries showed that only 32.1% (27 in 84) studies observed an optimal adherence above 90%.9,14,15 Many studies have focused on the barriers and facilitators to adherence, as sociodemographic (eg income, treatment self-efficacy) factors, psychosocial (eg depression, use of drugs) factors, as well as ART’s side effects (eg nausea, vomiting) could prevent HIV+ patients from correctly taking ART.16,17 A few studies adopted a theory-based model, the Information–Motivation–Behavioral Skills (IMB) model, to study inconsistent adherence to ART.18–20 These studies utilized the LifeWindows Information–Motivation–Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ), which is comprised of three interrelated sections: information section, motivation section, and behavioral skills section.21 According to the IMB model, acquiring comprehensive information about ART serves as the prerequisite to the motivation and behavioral change of ART adherence.22 Fisher classified items in the information section into two dimensions: specific information about adherence and heuristics concerning adherence. The motivation section consists of both independent and interdependent dimensions. The independent dimension, personal motivation, addresses motivation from personal perspectives while the interdependent dimension, social motivation, addresses motivation from social perspectives. When HIV+ patients hold positive views of the advantage of adherence, and receive encouragement from important people within their social networks, they are more likely to foster stronger motivations to stay in optimal adherence to ART. Adherence-related behavioral skills refer to patients’ self-efficacy about adhering to ART and about their abilities of putting the skills and motivations into practice. Once HIV+ patients acquire relevant and comprehensive information about ART, have strong adherence-related motivations and behavioral skills, they should be more likely to adhere to ART treatment. The LW-IMB-AAQ has been well implemented to strengthen adherence to ART in many Western countries.18–20,23 However, few studies have examined LW-IMB-AAQ in relation to ART adherence among HIV+ populations in Asia. And almost no data is available on the reliability and validity of this questionnaire among HIV+ populations in China. Rongkavilit et al applied the IMB model to assess ART adherence among Thai HIV+ youth, a representative Asian population, and found the model definitions for information and behavioral skills were suitable for that population, while model definition for motivation needed further support considering the different context of cultural background (for example, different religions such as Buddhism, Moslem, Taoism and so on).24 However, compared with its role in the Thai culture, religion has a lesser role to play in shaping the national culture in China. In this study, we applied the IMB model to a representative sample of HIV+ population in Shanghai, China, and examined the psychometric properties of the LW-IMB-AAQ. We sought to extend the applicability of the questionnaire to explain HIV+ patients’ ART adherence based on the IMB model to the Chinese population, and to lay the foundation for further research using the IMB model in this population.

Methods

Participants

Participants were recruited from 11 community health centers in Shanghai’s Putuo district. Eligibility requirements included being at least 18 years old, reporting an HIV seropositive status, using ART, residing in Shanghai, and willing to complete the questionnaire. All participants were required to provide informed consent. We took measures to ensure participants’ privacy during recruitment and enrollment, and all questionnaires will be destroyed after 2 years. Every participant is rewarded with 50 yuan (approximately $7) for completing the questionnaire. Meanwhile, 50 participants were recruited from Shanghai public health clinical center, Shanghai, China. Eligibility requirements and the protection of participants’ privacy were as same as above. These people were asked to finish firstly the print-out questionnaire and secondly, the electronic edition of the questionnaire and the interval was 3 months. The collecting data from these 50 participants were used for test–retest reliability.

Questionnaire

The questionnaire includes self-reported demographic characteristics, the modified version of the Community Programs for Clinical Research on AIDS Antiretroviral Medication Self-Report (CPCRA) and the LifeWindows Information–Motivation–Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ). The CPCRA contains the name, daily frequency and dose of proscribed drugs, and the exact amount of drugs that they have missed in the past 7 days. ART adherence was calculated by the ratio of the drug doses that they actually took to their prescribed drug doses. The sample was divided into two groups based on ART adherence: a high adherence group (>95% adherence) and a low adherence group (<95% adherence).25 The LW-IMB-AAQ was translated into Chinese to assess ART-related information (9 items), motivation (10 items), and behavioral skills (13 items). Each of the nine items used to assess ART-related information had a score of 0 or 1, and the total score ranged between 0 and 9. Items in the motivation and behavioral skills constructs are scored from 1 to 5. The total score for the motivation construct ranges from 10 to 50, and ranged from13 to 65 for the behavioral construct.

Data Analysis

Item Analysis

The mean and standard deviation (SD) of every item in the questionnaire was described. Then, the critical ratio (CR) was calculated for every item by SPSS 22. The critical ratio (CR) should be higher than 3 and statistically significant.26 Meanwhile, the correlation coefficient between each item and the total scale scores was checked.

Reliability

Internal consistency, split-half reliability and test–retest reliability were assessed for the whole questionnaire. Cronbach’s α coefficient was used for internal consistency of the three sections and total questionnaire, along with Spearman–Brown coefficient for split-half reliability of the total scale, while the interclass correlation coefficient (ICC) was assessed for the test–retest reliability of the three sections and total questionnaire. A value of α above 0.7 is considered as acceptable.27 The bigger the Spearman–Brown coefficients, the more stable the scale is.28 ICC lower than 0.4 is considered low, with 0.4–0.6 considered normal, 0.6–0.8 considered moderate and higher than 0.8 considered high.29

Validity

Exploratory factor analysis (EFA) was firstly conducted with SPSS 22 to extract the factor structure of the three model sections: information, motivation and behavioral skills. In EFA, principal components analysis with varimax rotation was used. The Kaiser-Meyer-Olkin measure and Bartlett’s sphericity were conducted for the legitimacy of the analysis. Then, confirmatory factor analysis (CFA) was employed with SPSS AMOS 24 to test the fitness of the questionnaire. The fit indices were calculated byχ2, degree of freedom (df), p-value, χ2/df, comparative fit index (CFI), goodness of fit index (GFI) and root-mean-square error of approximation (RMSEA). The reference values for every fitness index were p>0.05, χ2/df<3, CFI>0.9, GFI>0.9 and RMSEA<0.08.30 Then, the convergent validity was tested by the value of the average variance extracted (AVE), which was considered acceptable if the value of AVE was higher than 0.5. Discriminant validity was decided by comparison of the subscale’s value of the square root of AVE with the correlation coefficients of the specific subscale with those of other subscales.31

Results

Adherence-Related Behavior and Demographic Characteristics

We recruited 426 participants from 11 community health centers in Shanghai’s Putuo district, of which, 95.3% reported a high level of adherence (>95% adherence). Of these 426 participants (Table 1), 60.8% were 18–40 years old, 94.4% were male, 51.6% were homosexual, 65.5% were single, 54.7% reported homosexual transmission, 75.6% were in the HIV infection stage, 67.0% achieved a college degree or above and 92.5% earned more than 3000 yuan every month. None of these demographic characteristics were relevant to ART adherence (p>0.05). As is shown in Table 2, the mean scores of the information section and the social behavioral skills section are significantly different between high and low adherence groups (p<0.05) while there is no difference in the motivation section between the two groups.
Table 1

Demographic Characteristics of the Participants (N=426) and Their Relationship with ART Adherence

N (%)n in High Adherence Group (n/N%)p
Age
 18–40259(60.8%)247(95.4%)0.867
 41–60111(26.1%)105(94.6%)
 61–8056(13.1%)54(96.4%)
Sex
 Male402(94.4%)383(95.3%)1
 Female24(5.6%)23(95.8%)
Education
 Primary school or below3(0.7%)3(100%)0.425
 Junior high school39(9.1%)36(92.3%)
 Senior high school86(20.2%)84(97.7%)
 College degree or above298(67.0%)283(95.0%)
Marital Status
 Single279(65.5%)268(96.1%)0.457
 Currently married104(24.4%)96(92.3%)
 Divorced38(8.9%)37(97.4%)
 Widowed5(1.2%)5(100%)
Income, Yuan (0.15$)/Month
 ≤300032(7.5%)30(93.8%)0.564
 3000—600099(23.2%)92(92.9%)
 6001—12,000163(38.3%)157(96.3%)
 ≥12,000132(31.0%)127(96.3%)
Sexual Orientation
 Heterosexual109(25.6%)107(98.2%)0.123
 Homosexual220(51.6%)210(95.5%)
 Bisexual52(12.2%)49(94.2%)
 Pansexual3(0.7%)3(100%)
 Unsure42(9.9%)37(88.1%)
Transmission
 Heterosexual76(17.8%)74(97.4%)0.201
 Homosexual233(54.7%)221(94.8%)
 Blood-borne7(1.6%)7(100%)
 Intravenous drug use2(0.5%)1(50%)
 Unknown108(25.4%)103(95.4%)
Clinical Stage
 HIV infection stage322(75.6%)307(95.3%)1
 AIDS stage104(24.4%)99(95.2%)
Adherence
 High406 (95.3%)
 Low20 (4.7%)
Total426406
Table 2

The Mean Scores of Three Sections in Two Groups (N=426)

High Adherence (n=406) Mean/SDLow Adherence (n=20) Mean/SDp
Information3.71±2.8682.50±1.9870.016*
Motivation30.91±6.89630.20±5.4250.581
Behavioral skills55.72±6.53651.75±5.6180.006**

Notes: *p<0.05, **p<0.01.

Demographic Characteristics of the Participants (N=426) and Their Relationship with ART Adherence The Mean Scores of Three Sections in Two Groups (N=426) Notes: *p<0.05, **p<0.01.

Item Analysis

The results are shown in Table 3. Except motivation item 1, the CR coefficients of all items are higher than 3 (p< or = 0.001). Similarly, except motivation item 1, the scores of every item are significantly correlated with the total scores (p<0.001). Therefore, motivation item 1 is deleted for its low CR and item-total correlation.
Table 3

Item Analysis for the LW-IMB-AAQ

ItemMean±SDCRpItem-Total Correlationp
Information
 10.43±0.4958.804<0.0010.576<0.001
 20.38±0.48514.775<0.0010.515<0.001
 30.38±0.4864.1960.0010.424<0.001
 40.30±0.4579.349<0.0010.413<0.001
 50.61±0.4898.195<0.0010.494<0.001
 60.15±0.4589.387<0.0010.382<0.001
 70.56±0.49723.689<0.0010.575<0.001
 80.58±0.49523.689<0.0010.613<0.001
 90.28±0.44914.775<0.0010.478<0.001
Motivation
 11.78±0.7490.3250.7490.1140.021
 22.88±1.1828.179<0.0010.504<0.001
 33.15±1.27638.004<0.0010.659<0.001
 43.90±0.7935.371<0.0010.408<0.001
 54.44±1.2495.57<0.0010.256<0.001
 63.32±1.23015.317<0.0010.438<0.001
 73.15±1.21322.59<0.0010.647<0.001
 82.52±1.06714.236<0.0010.364<0.001
 93.06±1.12324.171<0.0010.502<0.001
 102.78±1.11914.146<0.0010.514<0.001
Behavioral Skills
 14.01±0.76711.533<0.0010.524<0.001
 23.92±0.8434.49<0.0010.403<0.001
 34.38±0.62318.833<0.0010.599<0.001
 44.42±0.5737.654<0.0010.649<0.001
 53.64±0.8678.253<0.0010.456<0.001
 64.43±0.5549.759<0.0010.654<0.001
 74.39±0.58125.115<0.0010.683<0.001
 84.44±0.54711.075<0.0010.72<0.001
 94.49±0.53211.111<0.0010.724<0.001
 104.48±0.52310.746<0.0010.718<0.001
 114.48±0.59110.921<0.0010.705<0.001
 124.46±0.58621.109<0.0010.734<0.001
 134.14±0.75220.569<0.0010.539<0.001

Abbreviation: CR, critical ratio.

Item Analysis for the LW-IMB-AAQ Abbreviation: CR, critical ratio.

Reliability

The results are shown in Table 4. All Cronbach’s α coefficients for the three sections and total questionnaire are higher than 0.7, with ICC all higher than 0.6 (p<0.001). And the Spearman–Brown coefficient for the total scale is 0.825. The reliability of the questionnaire is considered acceptable.
Table 4

The Reliability of the LW-IMB-AAQ

α (n=426)ICC (n=50)Spearman–Brown Coefficient
Information0.8480.643***0.825
Motivation0.8130.654***
Behavioral skills0.9150.626***
Total0.8890.799***

Notes: ***p<0.001, α, Cronbach’s α coefficients.

Abbreviation: ICC, interclass correlation coefficient

The Reliability of the LW-IMB-AAQ Notes: ***p<0.001, α, Cronbach’s α coefficients. Abbreviation: ICC, interclass correlation coefficient

Validity

EFA

Table 5 shows the result of the questionnaire. The KMO value of the Information section is 0.851 and Bartlett’s sphericity is χ2 = 1368.327 (p <0.001). And all items are reserved. The KMO value of the motivation section is 0.864 and Bartlett’s sphericity is χ2 = 1395.851 (p <0.001). And all items without motivation item 1 are reserved. The KMO value of the Behavioral Skills section is 0.944 and Bartlett’s sphericity is χ2 = 4539.052 (p <0.001). And all items are reserved.
Table 5

Exploratory Factor Analysis of the Questionnaire

Subscales
InformationSubscale 1Subscale 2
1: I know how each of my current HIV medications is supposed to be taken (for example whether or not my current medications can be taken with food, herbal supplements, or other prescription medications).0.609
2: I know what to do if I miss a dose of any of my HIV medications (for example, whether or not to take the pill (s) later).0.600
3: Skipping a few of my HIV medications from time to time would not really hurt my health.0.757
4: I know what the possible side effects of each of my HIV medications are.0.725
5: As long as I am feeling healthy, missing my HIV medications from time to time is OK.0.834
6: I understand how each of my HIV medications works in my body to fight HIV.0.787
7: If I do not take my HIV medications as prescribed, these kinds of medications may not work for me in the future.0.665
8: I believe that if I take my HIV medications as prescribed, I will live longer.0.600
9: I know how my HIV medications interact with alcohol and street drugs.0.745
MotivationSubscale 1Subscale 2Subscale 3
2: I get frustrated taking my HIV medications because I have to plan my life around them.0.771
3: I do not like taking my HIV medications because they remind me that I am HIV+.0.783
4: I feel that my healthcare provider takes my needs into account when making recommendations about which HIV medications to take.0.951
5: Most people who are important to me who know I am HIV positive support me in taking my HIV medications.0.924
6: My healthcare provider does not give me enough support when it comes to taking my medications as prescribed.0.509
7: It frustrates me to think that I will have to take these HIV medications every day for the rest of my life.0.808
8: I am worried that the HIV medications I have been prescribed will hurt my health.0.727
9: It upsets me that the HIV medications I have been prescribed can affect the way I look.0.779
10: It upsets me that the HIV medications I have been prescribed can cause side effects.0.829
Behavioral skillsSubscale 1Subscale 2
1: How hard or easy is it for you to stay informed about HIV treatment?0.780
2: How hard or easy is it for you to get the support you need from others for taking your HIV medications (for example, from friends, family, doctor, or pharmacist)?0.673
3: How hard or easy is it for you to get your HIV medication refills on time?0.697
4: How hard or easy is it for you to take your HIV medications when you are wrapped up in what you are doing?0.751
5: How hard or easy is it for you to manage the side effects of your HIV medications?0.747
6: How hard or easy is it for you to remember to take your HIV medications?0.798
7: How hard or easy is it for you to take your HIV medications because the pills are hard to swallow, taste bad, or make you sick to your stomach?0.852
8: How hard or easy is it for you to make your HIV medications part of your daily life?0.890
9: How hard or easy is it for you to take your HIV medications when your usual routine changes (for example, when you travel or when you go out with your friends)?0.903
10: How hard or easy is it for you to take your HIV medications when you do not feel good emotionally (for example, when you are depressed, sad, angry, or stressed out)?0.926
11: How hard or easy is it for you to take your HIV medications when you feel good physically and do not have any symptoms of your HIV disease?0.814
12: How hard or easy is it for you to take your HIV medications when you do NOT feel good physically?0.879
13: How hard or easy is it for you to talk to your health care provider about your HIV medications?0.633
Exploratory Factor Analysis of the Questionnaire

CFA

The CFA is performed to test the fitness of the questionnaire without the motivation subscale3 for that this scale is not suitable in this model. The result is shown in Table 6. The construct of the questionnaire is acceptable for p=0.381 (>0.05), χ2/df=1.068 (<3), CFI=0.999 (>0.9), GFI=0.995 (>0.9) and RMSEA=0.013 (<0.08). The final model includes three sections: information (2 subscales), motivation (2 subscales), behavioral skills (2 subscales). By referring to the pioneer study by Fisher and looking for commonness among the items in the same subscale, names of these subscales are defined.21 The information section has two subscales: the effect of ART on health, knowledge about ART and how to take it. The motivation section is classified as personal motivation and social motivation. The behavioral skills section includes self-efficacy about insisting on taking ART and objective abilities of using skills to improve ART adherence.
Table 6

Fitness of the LW-IMB-AAQ

χ2dfPχ2/dfCFIGFIRMSEA
7.47670.3811.0680.9990.9950.013

Note: χ2, Minimum Fit Function.

Abbreviations: df, degree of freedom; CFI, Comparative Fit Index; GFI, Goodness of Fit Index; RMSEA, Root Mean Square Error of Approximation.

Fitness of the LW-IMB-AAQ Note: χ2, Minimum Fit Function. Abbreviations: df, degree of freedom; CFI, Comparative Fit Index; GFI, Goodness of Fit Index; RMSEA, Root Mean Square Error of Approximation.

Convergent and Discriminant Validity

Table 7 shows the value of AVE of each subscale, the square root of every AVE value, and correlation coefficients between subscales. Except for the subscale about the effect of ART on health (approximately 0.5), the values of AVE of the other subscales are higher than 0.50, showing suitable convergent validity. The square roots of AVE are higher than any other correlation coefficients of every subscale with other subscales, which suggests acceptable discriminant validity.
Table 7

Convergent Validity and Discriminant Validity of the Questionnaire

AVESubscales
InformationKnowledgeEffect
 Knowledge0.5180.72
 Effect0.4860.620***0.697
MotivationPersonalSocial
 Personal0.5570.746
 Social0.9040.148**0.951
Behavioral skillsSelf-efficacyObjective abilities
 Self-efficacy0.5050.711
 Objective abilities0.7010.424***0.837

Notes: **p<0.01, ***p<0.001.

Abbreviations: AVE, average variance extracted; Knowledge, knowledge about ART and how to take it; Effect, the effect of ART on health; Personal, personal motivation; Social, social motivation; Self-efficacy, self-efficacy about insisting on taking ART; Objective abilities, objective abilities of using skills to improve ART adherence.

Convergent Validity and Discriminant Validity of the Questionnaire Notes: **p<0.01, ***p<0.001. Abbreviations: AVE, average variance extracted; Knowledge, knowledge about ART and how to take it; Effect, the effect of ART on health; Personal, personal motivation; Social, social motivation; Self-efficacy, self-efficacy about insisting on taking ART; Objective abilities, objective abilities of using skills to improve ART adherence.

Discussion

The final version of the LW-IMB-AAQ included 30 items measuring ART-related information, motivation and behavioral skills. Our results indicate that the questionnaire had good reliability and validity to asses ART adherence in Chinese HIV+ populations. The information section demonstrated good reliability and validity. Furthermore, the results of EFA showed that the information section can be divided into two subscales, one measuring the effect of ART on health, and the other measuring knowledge about ART and how to take it. This finding is consistent with Fisher’s study, as is mentioned before, in which he divided the information section into specific information about adherence and heuristics concerning adherence.21 The first section, the specific information about adherence, is similar to the subscale measuring knowledge about ART and how to take it in our study, including the regimen, correct ART use, side effects and drug interactions. However, the second section, heuristics concerning adherence, is a little different from the subscale measuring the effect of ART on health in our study. Heuristics concerning adherence refer to patients’ negative beliefs toward ART adherence. On top of this, the subscale measuring the effect of ART on health in our study also contains one item representing patients’ positive beliefs. And being cognizant of the positive effects of ART on health often leads to positive emotions, which in turn is related to positive behavior toward normalizing life.32 Item analysis suggests that motivation item 1 (“I am worried that other people might realize that I am HIV+ if they see me taking my HIV medications”) was not suitable for this model. After deleting motivation item 1, other items are divided into three subscales. But in the final CFA model, subscale3 (motivation item 4: “I feel that my healthcare provider takes my needs into account when making recommendations about which HIV medications to take”) should be deleted for that it is not considered as part of the motivation in the Putuo population in Shanghai. Therefore, the motivation section in the final model only has two subscales: personal motivation and social motivation, which is as same as the classification in the pioneer study by Fisher.21 Personal motivation refers to HIV+ patients’ negative emotions toward taking ART. Negative emotions come from persistent health problems and contribute to loss of hope. Hope motivates adherence-related behaviors and help HIV+ patients deal and live with HIV/AIDS positively.32 Therefore, negative emotions lead to non-adherence through the loss of hope. Besides, social motivation refers to social support from others such as doctors and families. A number of researches have demonstrated that social support has a great impact on ART adherence.33–35 All items in the behavioral skills section have been reserved for the acceptable validity and reliability. These items are divided into 2 subscales, one representing self-efficacy about insisting on taking ART and the other one representing objective abilities of using skills to improve ART adherence, which is as same as the classification in the pioneer study by Fisher.21 Self-efficacy is one’s confidence in completing a task or carrying out a certain action.36 HIV treatment self-efficacy refers to one’s confidence in his or her ability of adhering to a therapeutic regimen in spite of difficulties.37 And numerous studies have proved that adherence self-efficacy is able to predict optimal ART adherence.34,37,38

Limitations

The final version of the LW-IMB-AAQ is suitable for this population excluding items motivation items 1 and 4. However, this study has two limitations. Firstly, this study is limited to only one district in Shanghai and the sample is not that big. Besides, the participants are all managed by their communities while we have no access to HIV+ patients who are out of management. Therefore, this study may not be completely representative of the whole HIV+ patients in Shanghai.

Conclusion

The validity and reliability of this LW-IMB-AAQ are acceptable. The final questionnaire includes 30 items: 9 items in the information section (5 in the subscale measuring the effect of ART on health and 4 in the subscale measuring knowledge about ART and how to take it), 8 items in the motivation section (6 in the personal motivation subscale and 2 in the social motivation subscale) and 13 items in the behavioral skills section (9 items in the subscale representing self-efficacy about insisting on taking ART and 4 items in the subscale representing objective abilities of using skills to improve ART adherence).
  36 in total

Review 1.  HIV treatment as prevention among injection drug users.

Authors:  Evan Wood; Michael John Milloy; Julio S G Montaner
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

2.  An information-motivation-behavioral skills model of adherence to antiretroviral therapy.

Authors:  Jeffrey D Fisher; William A Fisher; K Rivet Amico; Jennifer J Harman
Journal:  Health Psychol       Date:  2006-07       Impact factor: 4.267

3.  The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES).

Authors:  Mallory O Johnson; Torsten B Neilands; Samantha E Dilworth; Stephen F Morin; Robert H Remien; Margaret A Chesney
Journal:  J Behav Med       Date:  2007-06-23

4.  The Information and Motivation and Behavioral Skills Model of ART Adherence among HIV-Positive Adults in Mexico.

Authors:  Carolina Santillán Torres Torija; Gabina Villagrán Vázquez; Silvia Susana Robles Montijo; Luz de Lourdes Eguiluz Romo
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-05-15

5.  Human agency in social cognitive theory.

Authors:  A Bandura
Journal:  Am Psychol       Date:  1989-09

6.  Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data.

Authors:  Kathy K Byrd; John G Hou; Ron Hazen; Heather Kirkham; Sumihiro Suzuki; Patrick G Clay; Tim Bush; Nasima M Camp; Paul J Weidle; Ambrose Delpino
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

7.  Commentary on meta-analysis of randomized controlled trials for HIV treatment adherence interventions. Research directions and implications for practice.

Authors:  Christopher M Gordon
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

Review 8.  Addressing the challenges of adherence.

Authors:  J A Bartlett
Journal:  J Acquir Immune Defic Syndr       Date:  2002-02-01       Impact factor: 3.731

9.  The patient's perspective on life with antiretroviral treatment: results of an 887-person survey.

Authors:  D R Bertholon; H Rossert; S Korsia
Journal:  AIDS Read       Date:  1999-10

10.  An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings.

Authors:  Keith J Horvath; Derek Smolenski; K Rivet Amico
Journal:  AIDS Care       Date:  2013-06-03
View more
  4 in total

1.  Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment.

Authors:  Bhavna H Chohan; Keshet Ronen; Brian Khasimwa; Daniel Matemo; Lusi Osborn; Jennifer A Unger; Alison L Drake; Ingrid A Beck; Lisa M Frenkel; John Kinuthia; Grace John-Stewart
Journal:  PLoS One       Date:  2021-08-18       Impact factor: 3.240

Review 2.  Behavioral Theories and Motivational Features Underlying eHealth Interventions for Adolescent Antiretroviral Adherence: Systematic Review.

Authors:  Alemitu Mequanint Bezabih; Kathrin Gerling; Workeabeba Abebe; Vero Vanden Abeele
Journal:  JMIR Mhealth Uhealth       Date:  2021-12-10       Impact factor: 4.773

3.  The Chinese version of the Quality of Life in Childhood Epilepsy Questionnaire-16-C (QOLCE-16-C): translation, validity, and reliability.

Authors:  Ping Tang; Qunfeng Lu; Yinghui Wu; Lin Wang; Wenjuan Tang; Yan Jiang; Liling Yang; Jianlin Ji; Xiaomin Sun; Jingmin Sun; Jie Yang
Journal:  Health Qual Life Outcomes       Date:  2022-03-28       Impact factor: 3.186

4.  Patient-Provider Communication and Information, Motivation, and Behavioral Skills in HIV-Positive Adults Initiating Antiretroviral Therapy in Haiti.

Authors:  Megan K Ramaiya; Elizabeth Haight; Jane M Simoni; Jean Marcxime Chéry; Witson Dervis; Wilner Genna; Jean Géto Dubé; Guirlène Calixte; Jean Gabriel Balan; Jean Guy Honoré; Nancy Puttkammer
Journal:  J Int Assoc Provid AIDS Care       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.